|
|||||
|
|
Absence of aprataxin gene mutations in a Greek cohort with sporadic early onset ataxia and normal GAA triplets in frataxin gene |
|
| Authors: | C Daiou K Christodoulou G Xiromerisiou M Panas E Dardiotis A Kladi M Speletas G Ntaios A Papadimitriou A Germenis Georgios M Hadjigeorgiou |
| Institution: | 1. Laboratory of Neurogenetics, Neuroscience Unit, Department of Neurology, Faculty of Medicine, University of Thessalia, Larissa, Greece 2. Cyprus Institute of Neurology and Genetics, Nicosia, Cyprus 3. Department of Neurology, Faculty of Medicine, Kapodistrian University of Athens, Athens, Greece 4. Institute of Biomedical Research and Technology, CERETETH, Larissa, Greece 5. Department of Immunology and Histocompatibility, School of Medicine, University Hospital of Thessaly, Larissa, Greece 6. First Propaedeutic Department of Internal Medicine, AHEPA Hospital, Aristotle University, Thessaloniki, Greece |
| Abstract: | Phenotype of patients with the aprataxin gene mutation varies and according to previous studies, screening of aprataxin gene could be useful, once frataxin gene mutation is excluded in patients with normal GAA expansion in frataxin gene. In the present study, we sought to determine possible causative mutations in aprataxin gene (all exons and flanking intronic sequences) in 14 Greek patients with sporadic cerebellar ataxia all but one without GAA expansion in frataxin gene (1 patient was heterozygous). No detectable point mutation or deletion was found in the aprataxin gene of all the patients. Our results do not confirm the previous studies. This difference may be attributed to the different populations studied and possible different genetic background. It is still questionable whether the screening for aprataxin mutation in Greek patients’ Friedreich ataxia phenotype is of clinical importance; larger, multicenter studies are necessary to clarify this issue. |
| Keywords: | |
| 本文献已被 SpringerLink 等数据库收录！ | |